Jagsonpal Pharmaceuticals Limited (JAGSNPHARM.NS) NSE
Currency In INR
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In INR
| Market Cap | 12.5B |
| Enterprise Value | 12.48B |
| P/E Ratio | 34.25 |
| PEG Ratio | -1.38 |
| Price/Sales Ratio | 5.22 |
| Price/Book Ratio | 5.55 |
| Enterprise/Revenue | 5.22 |
| Enterprise/EBITDA | 22.48 |
| Fiscal Year | March 31, 2026 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | 0.15 |
| Operating Margin | 0.18 |
| Return On Assets | 0 |
| Return On Equity | 0.17 |
| Revenue | 2.87B |
| Revenue/Share | 44.63 |
| Gross Profit | 1.83B |
| EBITDA | 679.9M |
| Net Income | 430.82M |
| Diluted EPS | 6.31 |
| Total Cash | 1.06B |
| Total Cash/Share | 0 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 0 |
| Book Value Per Share | 41.95 |
| 52-Week Change | -6.02 |
| 52-Week High | 264.5 |
| 52-Week Low | 155 |
| Moving Average 50 Days | 232.63 |
| Moving Average 200 Days | 202.69 |
| Average Volume | 507,706 |
| Shares Outstanding | 65.84M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 4 |
| Trailing Annual Dividend Yield | 1.72 |
| Payout Ratio | 0.37 |
| Last Split Factor | 8:1 |
| Last Split Date | July 20, 2004 |